108 related articles for article (PubMed ID: 30909319)
1. SLC1A5 glutamine transporter is a target of MYC and mediates reduced mTORC1 signaling and increased fatty acid oxidation in long-lived Myc hypomorphic mice.
Zhao X; Petrashen AP; Sanders JA; Peterson AL; Sedivy JM
Aging Cell; 2019 Jun; 18(3):e12947. PubMed ID: 30909319
[TBL] [Abstract][Full Text] [Related]
2. The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer.
Najumudeen AK; Ceteci F; Fey SK; Hamm G; Steven RT; Hall H; Nikula CJ; Dexter A; Murta T; Race AM; Sumpton D; Vlahov N; Gay DM; Knight JRP; Jackstadt R; Leach JDG; Ridgway RA; Johnson ER; Nixon C; Hedley A; Gilroy K; Clark W; Malla SB; Dunne PD; Rodriguez-Blanco G; Critchlow SE; Mrowinska A; Malviya G; Solovyev D; Brown G; Lewis DY; Mackay GM; Strathdee D; Tardito S; Gottlieb E; ; Takats Z; Barry ST; Goodwin RJA; Bunch J; Bushell M; Campbell AD; Sansom OJ
Nat Genet; 2021 Jan; 53(1):16-26. PubMed ID: 33414552
[TBL] [Abstract][Full Text] [Related]
3. Germline hypomorphic CARD11 mutations in severe atopic disease.
Ma CA; Stinson JR; Zhang Y; Abbott JK; Weinreich MA; Hauk PJ; Reynolds PR; Lyons JJ; Nelson CG; Ruffo E; Dorjbal B; Glauzy S; Yamakawa N; Arjunaraja S; Voss K; Stoddard J; Niemela J; Zhang Y; Rosenzweig SD; McElwee JJ; DiMaggio T; Matthews HF; Jones N; Stone KD; Palma A; Oleastro M; Prieto E; Bernasconi AR; Dubra G; Danielian S; Zaiat J; Marti MA; Kim B; Cooper MA; Romberg N; Meffre E; Gelfand EW; Snow AL; Milner JD
Nat Genet; 2017 Aug; 49(8):1192-1201. PubMed ID: 28628108
[TBL] [Abstract][Full Text] [Related]
4. Tubular CPT1A deletion minimally affects aging and chronic kidney injury.
Hammoud S; Ivanova A; Osaki Y; Funk S; Yang H; Viquez O; Delgado R; Lu D; Phillips Mignemi M; Tonello J; Colon S; Lantier L; Wasserman DH; Humphreys BD; Koenitzer J; Kern J; de Caestecker M; Finkel T; Fogo A; Messias N; Lodhi IJ; Gewin LS
JCI Insight; 2024 Feb; 9(6):. PubMed ID: 38516886
[TBL] [Abstract][Full Text] [Related]
5. mTORC1 promotes cell growth via m
Cho S; Lee G; Pickering BF; Jang C; Park JH; He L; Mathur L; Kim SS; Jung S; Tang HW; Monette S; Rabinowitz JD; Perrimon N; Jaffrey SR; Blenis J
Mol Cell; 2021 May; 81(10):2064-2075.e8. PubMed ID: 33756105
[TBL] [Abstract][Full Text] [Related]
6. Mesothelioma cancer cells are glutamine addicted and glutamine restriction reduces YAP1 signaling to attenuate tumor formation.
Adhikary G; Shrestha S; Naselsky W; Newland JJ; Chen X; Xu W; Emadi A; Friedberg JS; Eckert RL
Mol Carcinog; 2023 Apr; 62(4):438-449. PubMed ID: 36562471
[TBL] [Abstract][Full Text] [Related]
7. Phospholipase D Mediates Glutamine-Induced mTORC1 Activation to Promote Porcine Intestinal Epithelial Cell Proliferation.
Zhu M; Lu EQ; Yan L; Liu G; Huang K; Xu E; Zhang YY; Li XG
J Nutr; 2024 Apr; 154(4):1119-1129. PubMed ID: 38365119
[TBL] [Abstract][Full Text] [Related]
8. The crosstalk between MYC and mTORC1 during osteoclastogenesis.
Bae S; Oh B; Tsai J; Park PSU; Greenblatt MB; Giannopoulou EG; Park-Min KH
Front Cell Dev Biol; 2022; 10():920683. PubMed ID: 36060812
[TBL] [Abstract][Full Text] [Related]
9. SOD1 Phosphorylation by mTORC1 Couples Nutrient Sensing and Redox Regulation.
Tsang CK; Chen M; Cheng X; Qi Y; Chen Y; Das I; Li X; Vallat B; Fu LW; Qian CN; Wang HY; White E; Burley SK; Zheng XFS
Mol Cell; 2018 May; 70(3):502-515.e8. PubMed ID: 29727620
[TBL] [Abstract][Full Text] [Related]
10. CPT1A-mediated fatty acid oxidation confers cancer cell resistance to immune-mediated cytolytic killing.
Liu Z; Liu W; Wang W; Ma Y; Wang Y; Drum DL; Cai J; Blevins H; Lee E; Shah S; Fisher PB; Wang X; Fang X; Guo C; Wang XY
Proc Natl Acad Sci U S A; 2023 Sep; 120(39):e2302878120. PubMed ID: 37722058
[TBL] [Abstract][Full Text] [Related]
11. Nuclear VCP drives colorectal cancer progression by promoting fatty acid oxidation.
Huang Y; Wang F; Lin X; Li Q; Lu Y; Zhang J; Shen X; Tan J; Qin Z; Chen J; Chen X; Pan G; Wang X; Zeng Y; Yang S; Liu J; Xing F; Li K; Zhang H
Proc Natl Acad Sci U S A; 2023 Oct; 120(41):e2221653120. PubMed ID: 37788309
[TBL] [Abstract][Full Text] [Related]
12. MYC sensitises cells to apoptosis by driving energetic demand.
Edwards-Hicks J; Su H; Mangolini M; Yoneten KK; Wills J; Rodriguez-Blanco G; Young C; Cho K; Barker H; Muir M; Guerrieri AN; Li XF; White R; Manasterski P; Mandrou E; Wills K; Chen J; Abraham E; Sateri K; Qian BZ; Bankhead P; Arends M; Gammoh N; von Kriegsheim A; Patti GJ; Sims AH; Acosta JC; Brunton V; Kranc KR; Christophorou M; Pearce EL; Ringshausen I; Finch AJ
Nat Commun; 2022 Aug; 13(1):4674. PubMed ID: 35945217
[TBL] [Abstract][Full Text] [Related]
13. Glutamine addiction: a new therapeutic target in cancer.
Wise DR; Thompson CB
Trends Biochem Sci; 2010 Aug; 35(8):427-33. PubMed ID: 20570523
[TBL] [Abstract][Full Text] [Related]
14. Onco-Circuit Addiction and Onco-Nutrient mTORC1 Signaling Vulnerability in a Model of Aggressive T Cell Malignancy.
Wang X; Cornish AE; Do MH; Brunner JS; Hsu TW; Xu Z; Malik I; Edwards C; Capistrano KJ; Zhang X; Ginsberg MH; Finley LWS; Lim MS; Horwitz SM; Li MO
bioRxiv; 2024 Apr; ():. PubMed ID: 38617314
[TBL] [Abstract][Full Text] [Related]
15. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
Zhang Z; Liu R; Shuai Y; Huang Y; Jin R; Wang X; Luo J
Br J Cancer; 2020 Jan; 122(1):82-93. PubMed ID: 31819178
[TBL] [Abstract][Full Text] [Related]
16. A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells.
Yoo HC; Park SJ; Nam M; Kang J; Kim K; Yeo JH; Kim JK; Heo Y; Lee HS; Lee MY; Lee CW; Kang JS; Kim YH; Lee J; Choi J; Hwang GS; Bang S; Han JM
Cell Metab; 2020 Feb; 31(2):267-283.e12. PubMed ID: 31866442
[TBL] [Abstract][Full Text] [Related]
17. The role of the glutamine transporter ASCT2 in antineoplastic therapy.
Teixeira E; Silva C; Martel F
Cancer Chemother Pharmacol; 2021 Apr; 87(4):447-464. PubMed ID: 33464409
[TBL] [Abstract][Full Text] [Related]
18. The Human SLC1A5 Neutral Amino Acid Transporter Catalyzes a pH-Dependent Glutamate/Glutamine Antiport, as Well.
Scalise M; Mazza T; Pappacoda G; Pochini L; Cosco J; Rovella F; Indiveri C
Front Cell Dev Biol; 2020; 8():603. PubMed ID: 32733894
[TBL] [Abstract][Full Text] [Related]
19. Target the human Alanine/Serine/Cysteine Transporter 2(ASCT2): Achievement and Future for Novel Cancer Therapy.
Jiang H; Zhang N; Tang T; Feng F; Sun H; Qu W
Pharmacol Res; 2020 Aug; 158():104844. PubMed ID: 32438035
[TBL] [Abstract][Full Text] [Related]
20. Macrophage-derived glutamine boosts satellite cells and muscle regeneration.
Shang M; Cappellesso F; Amorim R; Serneels J; Virga F; Eelen G; Carobbio S; Rincon MY; Maechler P; De Bock K; Ho PC; Sandri M; Ghesquière B; Carmeliet P; Di Matteo M; Berardi E; Mazzone M
Nature; 2020 Nov; 587(7835):626-631. PubMed ID: 33116312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
